| Literature DB >> 34545071 |
Pavol Mikolas1, Kyra Bröckel2, Christoph Vogelbacher3,4,5, Dirk K Müller2,6,7, Michael Marxen2,6, Christina Berndt2, Cathrin Sauer2, Stine Jung2, Juliane Hilde Fröhner2,6, Andreas J Fallgatter8, Thomas Ethofer8,9, Anne Rau8, Tilo Kircher3,4,5, Irina Falkenberg3,4,5, Martin Lambert10, Vivien Kraft10, Karolina Leopold11, Andreas Bechdolf11, Andreas Reif12, Silke Matura12, Thomas Stamm13,14, Felix Bermpohl13, Jana Fiebig13, Georg Juckel15, Vera Flasbeck15, Christoph U Correll16,17,18, Philipp Ritter2, Michael Bauer2, Andreas Jansen3,4,5, Andrea Pfennig2.
Abstract
In psychiatry, there has been a growing focus on identifying at-risk populations. For schizophrenia, these efforts have led to the development of early recognition and intervention measures. Despite a similar disease burden, the populations at risk of bipolar disorder have not been sufficiently characterized. Within the BipoLife consortium, we used magnetic resonance imaging (MRI) data from a multicenter study to assess structural gray matter alterations in N = 263 help-seeking individuals from seven study sites. We defined the risk using the EPIbipolar assessment tool as no-risk, low-risk, and high-risk and used a region-of-interest approach (ROI) based on the results of two large-scale multicenter studies of bipolar disorder by the ENIGMA working group. We detected significant differences in the thickness of the left pars opercularis (Cohen's d = 0.47, p = 0.024) between groups. The cortex was significantly thinner in high-risk individuals compared to those in the no-risk group (p = 0.011). We detected no differences in the hippocampal volume. Exploratory analyses revealed no significant differences in other cortical or subcortical regions. The thinner cortex in help-seeking individuals at risk of bipolar disorder is in line with previous findings in patients with the established disorder and corresponds to the region of the highest effect size in the ENIGMA study of cortical alterations. Structural alterations in prefrontal cortex might be a trait marker of bipolar risk. This is the largest structural MRI study of help-seeking individuals at increased risk of bipolar disorder.Entities:
Mesh:
Year: 2021 PMID: 34545071 PMCID: PMC8452775 DOI: 10.1038/s41398-021-01598-y
Source DB: PubMed Journal: Transl Psychiatry ISSN: 2158-3188 Impact factor: 6.222
Socio-demographic characteristics. In order to assess the risk-associated structural alterations in help-seeking individuals, we divided the participants into no-risk, low-risk, and high-risk groups using the EPIbipolar assessment tool.
| No-risk | Low-risk | High-risk | Test | Post hoca | |
|---|---|---|---|---|---|
| 32 (12.2) | 130 (49.4) | 101 (38.4) | |||
| Sex female/male (%) | 10/22 (31.3/68.8) | 60/70 (46.2/53.8) | 57/44 (56.4/43.6) | No-risk ≠ high-risk; | |
| Age (SD) | 24.13 (3.08) | 24.78 (4.55) | 25.13 (4.42) | ||
| 1. No degree/attending school (%) | 0 (0.0) | 8 (6.3) | 4 (4.0) | ||
| 2. Secondary school (%) | 6 (18.8) | 18 (14.1) | 18 (18.0) | ||
| 3. High school (%) | 26 (81.3) | 102 (79.7) | 78 (78.0) | ||
| 1. Early recognition (%) | 15 (46.9) | 48 (36.9) | 50 (49.5) | ||
| 2. Depression (%) | 5 (15.6) | 68 (52.3) | 41 (40.6) | ||
| 3. ADHD (%) | 12 (37.5) | 14 (10.8) | 10 (9.9) | ||
| Yyes (%) | 11 (34.4) | 82 (63.6) | 53 (53.0) | No-risk ≠ low-risk; | |
| 1. Antidepressants (%) | 5 (15.6) | 67 (51.5) | 40 (39.6) | ||
| 2. Antipsychotics (%) | 1 (3.1) | 25 (19.2) | 11 (10.9) | ||
| 3. Mood stabilizers (%) | 0 (0.0) | 7 (5.4) | 4 (4.0) | ||
| 4. Anxiolytics & Sleep (%) | 1 (3.1) | 8 (6.2) | 7 (6.9) | ||
| 5. Psychostimulants (%) | 5 (15.6) | 6 (4.6) | 10 (9.9) | ||
| Smoking status | |||||
| 1. Never smoked (%) | 18 (56.3) | 63 (48.5) | 39 (38.6) | ||
| 2. Current smoker (%) | 9 (28.1) | 59 (45.4) | 52 (51.5) | ||
| 3. Past smoker (%) | 5 (15.6) | 8 (6.2) | 10 (9.9) | ||
| Cannabis present | |||||
| 0. No use (%) | 26 (81.3) | 90 (69.2) | 74 (73.3) | ||
| 1. <1×/month (%) | 1 (3.1) | 11 (8.5) | 9 (8.9) | ||
| 2. ~1×/month (%) | 0 (0.0) | 8 (6.2) | 6 (5.9) | ||
| 3. 2−9×/month (%) | 2 (6.3) | 8 (6.2) | 6 (5.9) | ||
| 4. ≥10×/month (%) | 3 (9.4) | 13 (10.0) | 6 (5.9) | ||
| Cannabis lifetime | |||||
| 0. No use (%) | 15 (46.9) | 48 (36.9) | 42 (41.6) | ||
| 1. <1×/month (%) | 8 (25.0) | 28 (21.5) | 19 (18.8) | ||
| 2. ~1×/month (%) | 0 (0.0) | 6 (4.6) | 5 (5.0) | ||
| 3. 2−9×/month (%) | 3 (9.4) | 17 (13.1) | 11 (10.9) | ||
| 4. ≥10×/month (%) | 6 (18.8) | 31 (23.8) | 22 (21.8) | ||
| First-degree relatives of BD patients | 0 (0.0) | 3 (2.3) | 17 (16.8) | ||
| Second-degree relatives of BD patients | 0 (0.0) | 0 (0.0) | 8 (7.9) | ||
In order to assess the risk-associated structural alterations in help-seeking individuals, we divided the participants into no-risk, low-risk, and high-risk groups using the EPIbipolar assessment tool.
Abbreviations. BAR-Criteria Bipolar-at-Risk-Criteria; BD Bipolar Disorder.
ap-values have been adjusted using Bonferroni Correction.
bFisher−Freeman−Halton’s exact test was used for variables with ≥1 expected cell counts <5. *p < 0.05; **p < 0.01; ***p < 0.001.
Fig. 1ROI-based analysis of cortical thickness by individuals at increased risk for development of bipolar disorder.
A Left inferior frontal gyrus—pars opercularis as defined by the Desikan−Killiany atlas. B Mean thickness of the left pars opercularis. The post hoc tests revealed a significantly thinner cortex of the left pars opercularis between no-risk and high-risk groups. The low-risk group tends to have lower thickness than the no-risk group, while having a greater thickness than the high-risk group. However, these differences were not significant. * denotes statistical significance at p = 0.012 (FDR-corrected). Error bars represent the 95% confidence intervals.
Results of the generalized linear models using the thickness of the left pars opercularis as an independent variable.
| Measure | Partial Eta squared | ||
|---|---|---|---|
| EPI | 4.475 | 0.012 | 0.035 |
| Sex | 1.417 | 0.235 | 0.006 |
| Smoking status | 0.336 | 0.715 | 0.003 |
| Medication | 2.171 | 0.142 | 0.009 |
| Site | 3.489 | 0.002 | 0.079 |
| Age | 9.152 | 0.003 | 0.036 |
| Cannabis present | 1.069 | 0.302 | 0.004 |
| Cannabis lifetime | 0.106 | 0.745 | 0.000 |
The significance test displays uncorrected p-values.
Results of the generalized linear models using the hippocampal volume as an independent variable.
| Measure | Partial Eta squared | ||
|---|---|---|---|
| EPI | 0.640 | 0.528 | 0.005 |
| Sex | 9.821 | 0.002 | 0.039 |
| Smoking status | 0.677 | 0.509 | 0.006 |
| Medication | 1.335 | 0.249 | 0.005 |
| Site | 11.566 | 0.000 | 0.221 |
| Age | 0.947 | 0.332 | 0.004 |
| Cannabis present | 0.094 | 0.760 | 0.000 |
| Cannabis lifetime | 0.197 | 0.868 | 0.004 |
| ICV | 108.688 | 0.000 | 0.308 |
The significance test displays uncorrected p-values. ICV—estimated total intracranial volume.